Business ❯ Healthcare ❯ Biotechnology

Clinical Trials

Drug Development Precision Medicine Osteoarthritis Psychedelic Treatments Cancer Treatment Oral Therapeutics Immune-Modulating Therapies Drug Delivery Gedatolisib Development Pharmaceutical Partnerships T Cell Therapy Cancer Treatments Regulatory Affairs Cell Therapy

Cedar Grove’s Q1 Letter Reaffirms Stock-Picking Focus, Highlights Evolv, The RealReal and Abivax

The firm says AI tailwinds will drive key holdings despite recent market turmoil.

ImmunityBio Extends Rally to 52-Week High on Anktiva Sales, Saudi Approval and Trial Progress

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

Enlivex Raises $212 Million to Build RAIN Token Treasury, Plans Matteo Renzi Board Appointment

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

BioRestorative Prices $1.085 Million Direct Offering at $1.60 With Concurrent Warrants

FDA Approves Papzimeos as First Therapy for Adult Recurrent Respiratory Papillomatosis